Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $3.06 billion. The enterprise value is $1.91 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 250.25 million shares outstanding. The number of shares has increased by 19.94% in one year.
| Current Share Class | 214.74M |
| Shares Outstanding | 250.25M |
| Shares Change (YoY) | +19.94% |
| Shares Change (QoQ) | +2.10% |
| Owned by Insiders (%) | 3.90% |
| Owned by Institutions (%) | 77.02% |
| Float | 201.28M |
Valuation Ratios
The trailing PE ratio is 122.30 and the forward PE ratio is 16.79.
| PE Ratio | 122.30 |
| Forward PE | 16.79 |
| PS Ratio | 0.32 |
| Forward PS | 0.27 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | 3.22 |
| P/OCF Ratio | 3.13 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 21.33, with an EV/FCF ratio of 2.01.
| EV / Earnings | 74.99 |
| EV / Sales | 0.21 |
| EV / EBITDA | 21.33 |
| EV / EBIT | 33.30 |
| EV / FCF | 2.01 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.37.
| Current Ratio | 0.82 |
| Quick Ratio | 0.73 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 3.60 |
| Debt / FCF | 0.39 |
| Interest Coverage | 2.41 |
Financial Efficiency
Return on equity (ROE) is 2.87% and return on invested capital (ROIC) is 2.78%.
| Return on Equity (ROE) | 2.87% |
| Return on Assets (ROA) | 0.85% |
| Return on Invested Capital (ROIC) | 2.78% |
| Return on Capital Employed (ROCE) | 4.16% |
| Revenue Per Employee | $3.82M |
| Profits Per Employee | $10,597 |
| Employee Count | 2,400 |
| Asset Turnover | 2.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $7.31 million in taxes.
| Income Tax | 7.31M |
| Effective Tax Rate | 21.85% |
Stock Price Statistics
The stock price has decreased by -30.47% in the last 52 weeks. The beta is 1.75, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | -30.47% |
| 50-Day Moving Average | 13.68 |
| 200-Day Moving Average | 16.00 |
| Relative Strength Index (RSI) | 43.85 |
| Average Volume (20 Days) | 4,206,896 |
Short Selling Information
The latest short interest is 17.23 million, so 6.88% of the outstanding shares have been sold short.
| Short Interest | 17.23M |
| Short Previous Month | 21.13M |
| Short % of Shares Out | 6.88% |
| Short % of Float | 8.56% |
| Short Ratio (days to cover) | 4.18 |
Income Statement
In the last 12 months, Oscar Health had revenue of $9.18 billion and earned $25.43 million in profits. Earnings per share was $0.10.
| Revenue | 9.18B |
| Gross Profit | 1.84B |
| Operating Income | 57.27M |
| Pretax Income | 23.89M |
| Net Income | 25.43M |
| EBITDA | 89.41M |
| EBIT | 57.27M |
| Earnings Per Share (EPS) | $0.10 |
Full Income StatementBalance Sheet
The company has $2.15 billion in cash and $373.75 million in debt, giving a net cash position of $1.15 billion or $4.61 per share.
| Cash & Cash Equivalents | 2.15B |
| Total Debt | 373.75M |
| Net Cash | 1.15B |
| Net Cash Per Share | $4.61 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 4.05 |
| Working Capital | -618.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $978.19 million and capital expenditures -$27.90 million, giving a free cash flow of $950.30 million.
| Operating Cash Flow | 978.19M |
| Capital Expenditures | -27.90M |
| Free Cash Flow | 950.30M |
| FCF Per Share | $3.80 |
Full Cash Flow StatementMargins
Gross margin is 20.10%, with operating and profit margins of 0.62% and 0.28%.
| Gross Margin | 20.10% |
| Operating Margin | 0.62% |
| Pretax Margin | 0.36% |
| Profit Margin | 0.28% |
| EBITDA Margin | 0.97% |
| EBIT Margin | 0.62% |
| FCF Margin | 10.35% |